The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
C-reactive protein elevation and disease activity in patients with coronary artery disease
Abstract
AIMS: We sought to assess (1) whether C-reactive protein (CRP) is an independent predictor of future cardiovascular events after adjustment for coronary artery disease (CAD) severity and (2) whether CRP levels correlate with number of angiographically complex coronary artery stenosis. METHODS AND RESULTS: We studied 825 consecutive angina patients (mean age 63+/-10 years, 74% men), 700 with chronic stable angina (CSA) and 125 with acute coronary syndromes without ST-segment elevation (ACS). The composite endpoint of non-fatal acute myocardial infarction, hospital admission with class IIIb unstable angina and cardiac death was assessed at one year follow-up. Hs-CRP level was higher in CSA patients with the combined end-point (P=0.03) after adjustment for number of diseased coronary arteries. Hs-CRP was also significantly higher in patients with ACS compared to CSA ( P=0.004) and correlated with number of complex angiographic stenoses (r=0.36, P=0.01). Hs-CRP was also increased in patients with NYHA functional class III or IV compared to those in class I or II (p<0.0001). CONCLUSIONS: CRP levels predict future cardiovascular events independently of CAD severity and correlate with number of angiographically complex coronary artery stenosis in patients with ACS. Thus, CRP levels are a marker of atheromatous plaque vulnerability and CAD activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Is obesity an inflammatory condition?
Das, U. N. (2001) · Nutrition · doi:10.1016/s0899-9007(01)00672-4 · Cited by 799 · cited 1×
“Inflammation could be the common link between obesity and cardiovascular disease.(24) Another important finding of the present study is the higher serum CRP levels in CSA patients with NYHA functional class III or IV compared to patients with class I or II.”
BackgroundRegulation of complement activation by C-reactive protein
Mold, C., Gewurz, H., & Du Clos, T. W. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00007-7 · Cited by 326
Cited by
Gershlick, A. H., Khan, J. N., Kelly, D. J., Greenwood, J. P., Sasikaran, T., Curzen, N., Blackman, D. J., Dalby, M., Fairbrother, K. L., Banya, W., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.12.038 · Cited by 824
Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression
Jernås, M., Palming, J., Sjöholm, K., Jennische, E., Svensson, P.-A., Gabrielsson, B. G., Levin, M., Sjögren, A., Rudemo, M., Lystig, T. C., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5678fje · Cited by 454
Zouridakis, E., Avanzas, P., Arroyo-Espliguero, R., Fredericks, S., & Kaski, J. C. (2004) · Circulation · doi:10.1161/01.cir.0000142664.18739.92 · Cited by 274
Self-citationLiu, Y., Ye, T., Chen, L., Jin, T., Sheng, Y., Wu, G., & Zong, G. (2021) · Coronary Artery Disease · doi:10.1097/mca.0000000000001037 · Cited by 179
Antibiotic prescribing in general medical and surgical specialties: a prospective cohort study
Charani, E., de Barra, E., Rawson, T. M., Gill, D., Gilchrist, M., Naylor, N. R., & Holmes, A. H. (2019) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-019-0603-6 · Cited by 62
Metadata
- Authors
- Arroyo-Espliguero, R.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-03
- Volume
- 25
- Issue
- 5
- Pages
- 401-408
- ISSN
- 0195-668X (ISSN-L)
- OpenAlex
- W2009877312
- Cited by
- 228
- References
- 3
- FWCI
- 16.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.